AlzChem Group AG (LON:0ACT)

Market Cap	582.21M
Revenue (ttm)	468.95M
Net Income (ttm)	41.69M
Shares Out	n/a
EPS (ttm)	4.10
PE Ratio	13.97
Forward PE	n/a
Dividend	1.03 (1.52%)
Ex-Dividend Date	May 8, 2024

Volume	4,185
Average Volume	820
Open	67.00
Previous Close	66.80
Day's Range	66.60 - 68.00
52-Week Range	18.74 - 53.56
Beta	1.16
RSI	62.05
Earnings Date	Feb 28, 2025

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the...

• Industry: Chemicals and Allied Products
• Founded: 1908
• Employees: 1,708
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ACT

Financial Performance

In 2023, AlzChem Group AG's revenue was 545.79 million, a decrease of -0.68% compared to the previous year's 549.53 million. Earnings were 34.62 million, an increase of 15.20%.

Financial numbers in EUR